Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice - Wikidata - awgldk - TriplyDB

Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice

Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice

http://www.wikidata.org/entity/Q33976250

about

Therapeutic efficacy of Poly(DL-lactide-Co-Glycolide)-encapsulated antitubercular drugs against Mycobacterium tuberculosis infection induced in mice Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid Preparation and characterization of beta-glucan particles containing a payload of nanoembedded rifabutin for enhanced targeted delivery to macrophages.Characterization, activity, and computer modeling of a molecular inclusion complex containing rifaldazine 25-Hydroxyvitamin D(3)-loaded PLA microspheres: in vitro characterization and application in diabetic periodontitis models.Formation of inhalable rifampicin-poly(L-lactide) microparticles by supercritical anti-solvent process.Preparation, in vitro characterization, and in vivo pharmacokinetic evaluation of respirable porous microparticles containing rifampicin.

P2860

Q28345268-E755ED62-F9A5-4349-9BD9-0B0133DC6780 Q28365194-058B4AEA-08E6-4926-9509-09CC0CF68FB0 Q33667215-BC9B0770-00A9-4B38-85AD-9531C1926E66 Q36587699-CF196654-31E0-4C9B-9A54-19B4DFB8D29C Q36882152-D15A2E6F-F893-4BD0-89E1-06D123BB14D6 Q41989434-76EE50A1-9E7B-44B8-924A-48D8D235EA40 Q42148661-C9C2AA62-E8B3-458D-BF14-B37A36DEE4A0

P2860

Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice

http://www.wikidata.org/entity/Q33976250

description

1999 nî lūn-bûn

@nan

1999 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

name

Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice

@ast

Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice

@en

type

label

Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice

@ast

Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice

@en

prefLabel

Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice

@ast

Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice

@en

P1433

Q33976250-E1866223-CB08-4D93-91E1-64101FF680B8

P1476

Q33976250-3F03F29E-1946-4314-93E9-2BE613D46B55

P2093

Q33976250-247657A0-39AF-489B-AD34-56F07D5EFB6F

Q33976250-35FB3339-5D5E-4B1B-88F2-3E95BC36DD37

Q33976250-8C568CAD-B1EC-4990-ADA2-39AC93663C9A

Q33976250-A7537B9D-A7E1-4F4C-B315-CEC7B2A0B466

Q33976250-A7C23028-7AB7-48BC-A7B9-48DB8386500F

P2860

Q33976250-05C92FD8-4BF0-418D-B240-D5D971931B54

Q33976250-0BD6C36A-5955-4A60-9A6A-D6AB96BBC31B

Q33976250-1D8F7E95-1552-44BB-9DB4-CDA3C39FC6C1

Q33976250-25E4B850-E7DA-491A-A77C-0F78808CE6F9

Q33976250-2C359C08-6069-4A78-8EC2-899DCB456D50

Q33976250-348CAE89-6D72-401C-BE5F-64A7DD3A53DC

Q33976250-38885F3C-2B04-48B3-B362-4CE6B39CE7F3

Q33976250-5F7764F1-A28D-4B11-B136-82270547A6EB

Q33976250-610E178C-9C5C-45A7-8303-B2B2261EAFBB

Q33976250-6ACFB43F-169D-4BC0-8BE3-EB953E8B724E

P304

Q33976250-E26D423F-576A-48DF-898A-8B52D180DFBD

P31

Q33976250-B0844DCB-6743-4A27-8C56-BD8726A9C6C8

P356

Q33976250-D713688A-56EF-4782-9474-666B560DB1A2

P407

Q33976250-61401189-DA29-48E8-ABC3-27EE309D12D5

P433

Q33976250-9A17E0CB-2FB6-45D9-A6D7-7416B91CC9E4

P478

Q33976250-74279D8D-74D0-4767-BE24-7DA7B120F2D2

P577

Q33976250-136FB8C2-400D-4E6C-BEC5-57026436F5B5

P698

Q33976250-5FB4B3A2-527F-4DDE-BF11-2B357498A837

P921

Q33976250-8BCE70C5-009F-47D7-BE85-D9A07AC344F3

P932

Q33976250-77C7799A-CDFD-41B0-957A-D9B519B922D7

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice

@en

P2093

D C Quenelle

http://www.w3.org/2001/XMLSchema#string

E L Barrow

http://www.w3.org/2001/XMLSchema#string

G A Winchester

http://www.w3.org/2001/XMLSchema#string

J K Staas

http://www.w3.org/2001/XMLSchema#string

W W Barrow

http://www.w3.org/2001/XMLSchema#string

P2860

An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome

Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons--Florida and New York, 1988-1991

Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice

Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice

Rationale for and efficacy of prolonged-interval treatment using liposome-encapsulated amikacin in experimental Mycobacterium avium infection.

Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophages

Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes.

Use of Mono Mac 6 human monocytic cell line and J774 murine macrophage cell line in parallel antimycobacterial drug studies.

Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice

Liposome-encapsulated gentamicin treatment of Mycobacterium avium-Mycobacterium intracellulare complex bacteremia in AIDS patients.

P304

1144-1151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.43.5.1144

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

1999-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10223927

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

89124

http://www.w3.org/2001/XMLSchema#string